会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Concatameric immunoadhesion molecule
    • 共聚蛋白免疫粘附分子
    • US07670602B2
    • 2010-03-02
    • US11739288
    • 2007-04-24
    • Yong-Hoon ChungJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • Yong-Hoon ChungJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • A61K39/395
    • C07K14/70507A61K2039/505C07K14/70521C07K14/7151C07K2319/00C07K2319/30
    • Disclosed are concatameric proteins comprising two soluble domains, in which the C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of an identical soluble domain or a distinct soluble domain of a biologically active protein. Also, the present invention discloses dimeric proteins formed by formation of intermolecular disulfide bonds at the hinge region of two monomeric proteins formed by linkage of a concatamer of two identical soluble extracellular regions of proteins involving immune response to an Fc fragment of an immunoglobulin molecule, their glycosylated proteins, DNA constructs encoding the monomeric proteins, recombinant expression plasmids containing the DNA construct, host cells transformed or transfected with the recombinant expression plasmids, and a method of preparing the dimeric proteins by culturing the host cells. Further, the present invention discloses pharmaceutical or diagnostic compositions comprising the dimeric protein or its glycosylated form.
    • 公开了包含两个可溶性结构域的连续蛋白质,其中生物活性蛋白质的可溶性结构域的C末端与生物活性蛋白质的相同可溶性结构域或不同可溶性结构域的N末端连接。 此外,本发明公开了通过在两个单体蛋白的铰链区上形成分子间二硫键而形成的二聚体蛋白,该两个单体蛋白是通过将免疫应答涉及免疫应答的两个相同的可溶胞外区的连接体与免疫球蛋白分子的Fc片段 糖基化蛋白质,编码单体蛋白的DNA构建体,含有DNA构建体的重组表达质粒,用重组表达质粒转化或转染的宿主细胞,以及通过培养宿主细胞制备二聚体蛋白质的方法。 此外,本发明公开了包含二聚体蛋白质或其糖基化形式的药物或诊断组合物。
    • 2. 发明授权
    • Polynucleotides encoding concatameric immunoadhesion molecules
    • 编码连接性免疫粘附分子的多核苷酸
    • US08372961B2
    • 2013-02-12
    • US12692392
    • 2010-01-22
    • Yong-Hoon ChungJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • Yong-Hoon ChungJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • C12N15/12
    • C07K14/70507A61K2039/505C07K14/70521C07K14/7151C07K2319/00C07K2319/30
    • Disclosed are concatameric proteins comprising two soluble domains, in which the C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of an identical soluble domain or a distinct soluble domain of a biologically active protein. Also, the present invention discloses dimeric proteins formed by formation of intermolecular disulfide bonds at the hinge region of two monomeric proteins formed by linkage of a concatamer of two identical soluble extracellular regions of proteins involving immune response to an Fc fragment of an immunoglobulin molecule, their glycosylated proteins, DNA constructs encoding the monomeric proteins, recombinant expression plasmids containing the DNA construct, host cells transformed or transfected with the recombinant expression plasmids, and a method of preparing the dimeric proteins by culturing the host cells. Further, the present invention discloses pharmaceutical or diagnostic compositions comprising the dimeric protein or its glycosylated form.
    • 公开了包含两个可溶性结构域的连续蛋白质,其中生物活性蛋白质的可溶性结构域的C末端与生物活性蛋白质的相同可溶性结构域或不同可溶性结构域的N末端连接。 此外,本发明公开了通过在两个单体蛋白的铰链区上形成分子间二硫键而形成的二聚体蛋白,该两个单体蛋白是通过将免疫应答涉及免疫应答的两个相同的可溶胞外区的连接体与免疫球蛋白分子的Fc片段 糖基化蛋白质,编码单体蛋白的DNA构建体,含有DNA构建体的重组表达质粒,用重组表达质粒转化或转染的宿主细胞,以及通过培养宿主细胞制备二聚体蛋白质的方法。 此外,本发明公开了包含二聚体蛋白质或其糖基化形式的药物或诊断组合物。
    • 3. 发明申请
    • CONCATAMERIC IMMUNOADHESION MOLECULE
    • 综合免疫分子
    • US20100278827A1
    • 2010-11-04
    • US12692392
    • 2010-01-22
    • Yong-Hoon CHUNGJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • Yong-Hoon CHUNGJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • A61K39/395C07K16/46C07H21/04C12N15/63C12N5/07C12P21/02A61P37/00
    • C07K14/70507A61K2039/505C07K14/70521C07K14/7151C07K2319/00C07K2319/30
    • Disclosed are concatameric proteins comprising two soluble domains, in which the C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of an identical soluble domain or a distinct soluble domain of a biologically active protein. Also, the present invention discloses dimeric proteins formed by formation of intermolecular disulfide bonds at the hinge region of two monomeric proteins formed by linkage of a concatamer of two identical soluble extracellular regions of proteins involving immune response to an Fc fragment pf an immunoglobulin molecule, their glycosylated proteins, DNA constructs encoding the monomeric proteins, recombinant expression plasmids containing the DNA construct, host cells transformed or transfected with the recombinant expression plasmids, and a method of preparing the dimeric proteins by culturing the host cells. Further, the present invention discloses pharmaceutical or diagnostic compositions comprising the dimeric protein or its glycosylated form.
    • 公开了包含两个可溶性结构域的连续蛋白质,其中生物活性蛋白质的可溶性结构域的C末端连接到生物活性蛋白质的相同可溶性结构域或不同可溶性结构域的N末端。 此外,本发明公开了通过在两个单体蛋白质的铰链区上形成分子间二硫键而形成的二聚体蛋白质,这两个单体蛋白质是通过将免疫应答的两个相同的可溶性细胞外区域与免疫球蛋白分子的Fc片段连接起来而形成的, 糖基化蛋白质,编码单体蛋白的DNA构建体,含有DNA构建体的重组表达质粒,用重组表达质粒转化或转染的宿主细胞,以及通过培养宿主细胞制备二聚体蛋白质的方法。 此外,本发明公开了包含二聚体蛋白质或其糖基化形式的药物或诊断组合物。
    • 4. 发明授权
    • Tetravalent etanercept
    • 四价依那西普
    • US07229962B2
    • 2007-06-12
    • US10363427
    • 2002-07-26
    • Yong-Hoon ChungJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • Yong-Hoon ChungJi-Woong HanHye-Ja LeeEun-Yong ChoiJin-Mi Kim
    • C07K14/715A61K38/16
    • C07K14/70507A61K2039/505C07K14/70521C07K14/7151C07K2319/00C07K2319/30
    • Disclosed are concatameric proteins comprising two soluble domains, in which the C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of an identical soluble domain or a distinct soluble domain of a biologically active protein. Also, the present invention discloses dimeric proteins formed by formation of intermolecular disulfide bonds at the hinge region of two monomeric proteins formed by linkage of a concatamer of two identical soluble extracellular regions of proteins involving immune response to an Fc fragment of an immunoglobulin molecule, their glycosylated proteins, DNA constructs encoding the monomeric proteins, recombinant expression plasmids containing the DNA construct, host cells transformed or transfected with the recombinant expression plasmids, and a method of preparing the dimeric proteins by culturing the host cells. Further, the present invention discloses pharmaceutical or diagnostic compositions comprising the dimeric protein or its glycosylated form.
    • 公开了包含两个可溶性结构域的连续蛋白质,其中生物活性蛋白质的可溶性结构域的C末端与生物活性蛋白质的相同可溶性结构域或不同可溶性结构域的N末端连接。 此外,本发明公开了通过在两个单体蛋白的铰链区上形成分子间二硫键而形成的二聚体蛋白,该两个单体蛋白是通过将免疫应答涉及免疫应答的两个相同的可溶胞外区的连接体与免疫球蛋白分子的Fc片段 糖基化蛋白质,编码单体蛋白的DNA构建体,含有DNA构建体的重组表达质粒,用重组表达质粒转化或转染的宿主细胞,以及通过培养宿主细胞制备二聚体蛋白质的方法。 此外,本发明公开了包含二聚体蛋白质或其糖基化形式的药物或诊断组合物。